We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.15 | 8.00 | 9.50 | - | 0.00 | 07:30:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.09 | 84.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/6/2017 11:38 | "my upside is pretty much infinite"Careful, that sort of talk upsets people. Best wishesww | wigwammer | |
27/6/2017 11:28 | Wig as previously stated, i dont want to buy any more, i have sufficient shares at basically zero, so am more than comfortable with my holding. If this fails, then all ive effectively lost is a few quid, but if it happens, then my upside is pretty much infinite. I no longer trust anything coming from RG's mouth, so am absolutely unwilling to invest any cash at the moment, whether that be for a potential near time gain, or, what i think will happen, a long term return, as if it transpires that it is still a long term trade, then there will be plenty more buying opportunities over the next 12 - 18 months. | tosh123 | |
27/6/2017 11:23 | Tosh"Manipulate""Mon | wigwammer | |
27/6/2017 11:20 | So despite knowing it was going to rise from 10p, you didn't buy any.Conviction stuff. | wigwammer | |
27/6/2017 11:10 | You're deluded Barrow Boy if you think I've got £100k's of my own money to throw at a tiny bio company, lol. Dear oh dear, you're just as delusional as the other mob, I've seen your type come and go for years with this company, the thing is I've made my money with Scancell, right now is not the time to buy, the next placing will be in single figures | wanderer1210_0 | |
27/6/2017 11:08 | Wig, 10p will only look like a bargain if the share price can be manipulated to in excess of 20p over the next few weeks / months ( eg ;- prior to the next MASSIVE round of funding ), otherwise, it will just be more money down the drain for private shareholders. This recent explosion in information flow / PR, is no accident. It is designed and timed, to lure people in and increase the share price in preparation for the funding. All the II's will be holding onto their shares waiting for the share price lift to happen, and then strategically sell into it at the last minute, just prior to the funding announcement. IMHO. | tosh123 | |
27/6/2017 10:50 | "It's a get out for the big boys in the last funding round,any significant rise will be sold into for a tidy profit."So the big boys make a risk free profit. The little guy ends up penniless.Given these easy profits, were you filling your boots when the shares recently traded around the 10p placing price? | wigwammer | |
27/6/2017 10:47 | Your negativity surprises me.Perhaps it's all you can do. | wigwammer | |
27/6/2017 10:24 | "it is good management to try and raise the profile of the company. The point that two nationals have run with the story suggests they have a decent story to tell." . Far from "good management"... Some might ask ... WHY... this 'APPARENT' change to - - " try and raise the profile of the company." pops-up now AFTER the recent 'LAND-GRAB' to which 'ordinary shareholders' were EXCLUDED ??? Puts J C's million+ 'punt' in a different light ... given the timing thereof . NO wonder some will say = "it stinks" . When a management team can do nothing right, it tells you something about trHYPERS. | the real lozan | |
27/6/2017 10:22 | It's a get out for the big boys in the last funding round,any significant rise will be sold into for a tidy profit. Wash rinse repeat. Nothing more nothing less imo | wanderer1210_0 | |
27/6/2017 10:12 | Tosh... it is possible that the management is bad bad bad. It is probable there are things which (with hindsight) they would do differently. But the most likely reality is that management have worked hard to progress the assets, and it is taking longer than expected.It's not the end of the world, and gives investors a chance to buy at a reasonable price i.e. without a hype premium. | wigwammer | |
27/6/2017 09:45 | Wig, exactly............. Furthermore, anyone buying in now will no doubt get diluted out of sight once the raising has been done. bad bad bad management. | tosh123 | |
27/6/2017 09:20 | "i wonder why"Tosh - they need to raise money. It isn't a secret.In that situation, it is good management to try and raise the profile of the company. The point that two nationals have run with the story suggests they have a decent story to tell.When a management team can do nothing right, it tells you something about sentiment. | wigwammer | |
27/6/2017 08:31 | Spooky.... we suddenly have articles in a national newspaper... funny that. After years and years of hiding, we suddenly get 2 days on the trot.. Call me an old cynic , but as per yesterdays post, keep an eye out for more of the same, as we get closer to the time of having to raise the money. Funny that it would appear, that the share price has suddenly become a focal point for the BOD, hmmmm i wonder why, especially as they have clearly never given it a second thought up until now. | tosh123 | |
26/6/2017 17:59 | "a fully funded on going phase III trial company"He means Immupharma and Lupuzor. Interesting he fails to mention that Lupuzor failed its first phase 3, had its rights returned, failed to find another partner (despite management claiming "great confidence" this would happen), that it was out of the clinic for 5 years, that it required a 60% dilution to get it back into the clinic, that it likely requires an additional phase 3, and is targeting an indication where only one product has seen success in 50 years.Perhaps wanderer is trying to hide these things from you, or perhaps (more likely) he just hasn't done a lot of research. Hope that helps. | wigwammer | |
26/6/2017 17:16 | Looks like the barrow boy is peddling his wares again ( apples and oranges) can anyone see a similarity between a fully funded on going phase III trial company and a nothing in trial company that does not even have any vaccine? | wanderer1210_0 | |
26/6/2017 16:48 | 10p on the bid and you think it's ticking up nicely. Should have gone to Broadmoor | terror | |
26/6/2017 15:15 | "My point, there has been zero financial benefit to date investing in Scancell"I don't care. I'm buying it now."Big pharma will win, PI's and VCT's will lose etc.."Silly statement with little to do with SCLP - the point that it has been ticked up a couple of times speaks volumes about the state of sentiment here.Evidently, PI's and VCT's sometimes win. | wigwammer | |
26/6/2017 14:12 | Wigwammer - My point, there has been zero financial benefit to date investing in Scancell. That cant be disputed, indeed the CLUB are so under water, their lifeline has gone. Big Pharma will win, PI's will lose and VCT's will lose. | terror | |
26/6/2017 13:10 | "SCIB and Moditope are worth nothing because the cash put into the business and promised has not grown the market cap."Sorry Terror, but again that is garbage.It is very common to find that a successful company/investment once traded beneath the value of its invested capital.Should have gone to an investment 101. | wigwammer | |
26/6/2017 13:00 | BoB One aspect, following the extentions to Lozan Towers, is a covered area, which has greatly enlarged our 'enjoyment of life' in this beautiful part of the world. Consumption - in moderation . I DID say "Hopefully" some smart Artsed lawyers !!! . With the comments turning towards 'various attempts to raise the share price prior to the final raising/ DILUTION ETC. regarding the VITAL FUNDING {Yet to be resolved}... Would it NOT be WISE to assume that those who CONTROL the large VITAL FUNDS that SCLP seek, WILL BE WELL AWARE of the TRUE SITUATION...irrespec Would it NOT be WISE to assume that those who CONTROL the large VITAL FUNDS that SCLP seek, 'HOLD ALL the ACES' where 'negociations' take place ??? Would it NOT be WISE to assume that those who CONTROL the large VITAL FUNDS that SCLP seek, ARE going to DICTATE the terms to their benefit ??? Would it NOT be WISE to assume that those who CONTROL the large VITAL FUNDS that SCLP seek, are not fools, or naive... in money matters??? CAN anyone - even the "STRONG BUY CLIQUE" - not see that MASSIVE DILUTION may NOT be an issue??? One could say, it is more likely to be = "On The CARDS" | the real lozan | |
26/6/2017 12:38 | Wigwammer - They have raised £23m to date, in addition they have had grants from Council and EMDA, sold to Arana Therapeutics, issued options etc, Bottom line is that all investors cash has resulted in a Market Cap that shows no growth. In summary - SCIB and Moditope are worth nothing because the cash put into the business and promised has not grown the market cap. Should have gone to SpecSavers. | terror | |
26/6/2017 11:28 | Lozan, You seem to be suggesting that any patents granted by the EPO to UK companies may be subject to challenge due to Brexit. Are you sure you haven't cracked open a bottle of red and hit the terrace a bit early today? The European Patent Organisation and the EPO have nothing whatsoever to do with the EU -they are not an EU body. Therefore, Brexit and the EU have no impact on European Patents. Either that or Juncker has slipped Albania and Turkey into the EU without anyone noticing. | bermudashorts | |
26/6/2017 11:27 | agema, i agree. there will no doubt be various attempts to raise the share price prior to the final raising. Unfortunately, this process is a bit too late, and is somewhat closing the gate after the horse has bolted. The implications of a total lack of any share price protection by the BOD are now coming home to roost. | tosh123 | |
26/6/2017 11:27 | AgemaThe market cap of SCLP is £32m.It is not factually correct to suggest that £20m is greater than £32m.With regard to dilution - IMM has seen a 60% dilution in tranches over the last 18 months. The first and largest tranche was at 26p.The shares are now 52p. Dilution does not necessarily result in a lower share price.The key similarity between IMM then and SCLP now - is that both have clinical stage assets that are difficult to value. Sentiment is key. So when I see it suggested that management are liars, the IP is worthless, dilution will only make it go down, that 20 is a bigger number than 32 - I get interested. The words could have been directly lifted from one board and placed on the other. Cheers, ww | wigwammer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions